SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal - Quaterly Results

14 Feb 2022 Evaluate
A fair growth of 11.06% in the revenue at Rs. 5145.30 millions was reported in the December 2021 quarter as compared to Rs. 4632.90 millions during year-ago period.Profit saw a slight increase of 12.21%to Rs. 452.00  millions from Rs. 402.80 millions.OP of the company witnessed a marginal growth to 934.80 millions from 918.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 5145.30 4632.90 11.06 14403.70 11879.80 21.25 17204.40 15072.60 14.14
Other Income 5.70 5.20 9.62 46.20 21.10 118.96 49.80 37.00 34.59
PBIDT 934.80 918.40 1.79 2841.40 2157.40 31.70 3278.70 2768.50 18.43
Interest 71.80 80.50 -10.81 231.30 262.30 -11.82 362.00 524.20 -30.94
PBDT 863.00 837.90 3.00 2610.10 1895.10 37.73 2916.70 2090.30 39.53
Depreciation 246.80 218.10 13.16 714.40 636.90 12.17 852.40 824.60 3.37
PBT 616.20 619.80 -0.58 1895.70 1258.20 50.67 2064.30 1265.70 63.10
TAX 164.20 217.00 -24.33 498.20 435.90 14.29 732.80 421.40 73.90
Deferred Tax -5.20 -10.20 -49.02 -20.30 -16.90 20.12 -62.70 74.40 -184.27
PAT 452.00 402.80 12.21 1397.50 822.30 69.95 1331.50 844.30 57.70
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 18.17 19.82 -8.35 19.73 18.16 8.63 19.06 18.37 3.75

Hikal Share Price

192.15 3.60 (1.91%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×